Mark Ensign, BS

Cristcot
Austin, Texas, United States

Disclosure information not submitted.

Presentation(s):

• ORF37-01 - Dual-dose Cosyntropin Stimulation Testing to Assess HPA-axis Safety and Identify Non-Study Corticosteroid Exposure in a Phase 3 Ulcerative Colitis Trial

  Sunday, June 14, 2026
  3:30 PM - 4:15 PM CT

• MON-507 - Dual-dose Cosyntropin Stimulation Testing to Assess HPA-axis Safety and Identify Non-Study Corticosteroid Exposure in a Phase 3 Ulcerative Colitis Trial

  Monday, June 15, 2026
  9:00 AM - 2:00 PM CT